skip to main content

S. 916: Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018

About the bill

Source: Republican Policy Committee

S. 916 would allow pharmacists to dispense medication-assisted treatments to doctors, rather than directly to patients, in an attempt to improve dispensing of implantable and injectable therapies developed to make abuse, misuse, and diversion more difficult.

Under the Controlled Substances Act (CSA), pharmacists can only dispense medication-assisted treatments directly to a patient. The legislation would change the CSA to allow pharmacists to dispense these treatments directly to doctors, who can then administer the treatment to the patient in an office-setting, and ensure the patient is also receiving behavioral therapy and ...

Sponsor and status

Bill Cassidy

Sponsor. Senior Senator for Louisiana. Republican.

Read Text »
Last Updated: May 23, 2018
Length: 6 pages

Apr 24, 2017


Passed Senate (House next) on May 23, 2018

This bill passed in the Senate on May 23, 2018 and goes to the House next for consideration.

The House Majority Leader indicated on Jun 8, 2018 that this bill may be considered in the week ahead.


80% chance of being enacted according to Skopos Labs (details)


Apr 24, 2017

Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.

Apr 26, 2017
Ordered Reported

A committee has voted to issue a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee.

May 23, 2018
Passed Senate (House next)

The bill was passed in a vote in the Senate. It goes to the House next. The vote was by Unanimous Consent so no record of individual votes was made.

Jun 8, 2018
On House Schedule

The House indicated that this bill would be considered in the week ahead.

Passed House

Signed by the President

S. 916 is a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“S. 916 — 115th Congress: Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018.” 2017. August 14, 2018 <>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from, the official portal of the United States Congress. is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.